{"id":"https://openalex.org/W7124288317","doi":"https://doi.org/10.3390/pharmaceutics18010115","title":"Effective Non-Invasive Delivery of Epigenetic Drugs Using Functionalized Accessory Unit Conjugates","display_name":"Effective Non-Invasive Delivery of Epigenetic Drugs Using Functionalized Accessory Unit Conjugates","publication_year":2026,"publication_date":"2026-01-15","ids":{"openalex":"https://openalex.org/W7124288317","doi":"https://doi.org/10.3390/pharmaceutics18010115","pmid":"https://pubmed.ncbi.nlm.nih.gov/41599222"},"language":"en","primary_location":{"id":"doi:10.3390/pharmaceutics18010115","doi":"https://doi.org/10.3390/pharmaceutics18010115","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics18010115","pdf_url":"https://www.mdpi.com/1999-4923/18/1/115/pdf?version=1768575221","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/1999-4923/18/1/115/pdf?version=1768575221","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073381113","display_name":"Toshihiko Tashima","orcid":"https://orcid.org/0009-0009-7250-1721","observed_orcids":["https://orcid.org/0009-0009-7250-1721"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Toshihiko Tashima","raw_affiliation_strings":["Tashima Laboratories of Arts and Sciences, 1239-5 Toriyama-cho, Kohoku-ku, Yokohama 222-0035, Kanagawa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tashima Laboratories of Arts and Sciences, 1239-5 Toriyama-cho, Kohoku-ku, Yokohama 222-0035, Kanagawa, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5073381113"],"corresponding_institution_ids":[],"apc_list":{"value":2900,"currency":"CHF","value_usd":3499},"apc_paid":{"value":2900,"currency":"CHF","value_usd":3499},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02834287,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"1","first_page":"115","last_page":"115"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.5692999958992004,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.5692999958992004,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.33889999985694885,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epigenetic-drugs","display_name":"epigenetic drugs","score":0.9340000152587891},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.8659999966621399},{"id":"https://openalex.org/keywords/epigenetic-modifiers","display_name":"epigenetic regulators","score":0.7919999957084656},{"id":"https://openalex.org/keywords/dna-methylation","display_name":"DNA methylation","score":0.6940000057220459},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9589999914169312},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.8939999938011169},{"id":"https://openalex.org/keywords/histone-acetyltransferase-inhibitors","display_name":"histone acetyltransferase inhibitors","score":0.9660000205039978},{"id":"https://openalex.org/keywords/microrna","display_name":"microRNA","score":0.921999990940094},{"id":"https://openalex.org/keywords/cell-penetrating-peptides","display_name":"cell-penetrating peptides","score":0.968999981880188},{"id":"https://openalex.org/keywords/tumor-homing-peptides","display_name":"tumor-homing peptides","score":0.9639999866485596},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8999999761581421},{"id":"https://openalex.org/keywords/nanoparticles","display_name":"nanoparticles","score":0.9319999814033508},{"id":"https://openalex.org/keywords/membrane-permeability","display_name":"membrane permeability","score":0.6399999856948853},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.9430000185966492}],"concepts":[{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.8727999925613403},{"id":"https://openalex.org/C2778305200","wikidata":"https://www.wikidata.org/wiki/Q174378","display_name":"Histone deacetylase","level":4,"score":0.660099983215332},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.5503000020980835},{"id":"https://openalex.org/C145059251","wikidata":"https://www.wikidata.org/wiki/Q310899","display_name":"microRNA","level":3,"score":0.5188999772071838},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.48969998955726624},{"id":"https://openalex.org/C2779979206","wikidata":"https://www.wikidata.org/wiki/Q1154602","display_name":"DNA methyltransferase","level":5,"score":0.4810999929904938},{"id":"https://openalex.org/C114691636","wikidata":"https://www.wikidata.org/wiki/Q5031434","display_name":"Cancer epigenetics","level":5,"score":0.4772999882698059},{"id":"https://openalex.org/C63016187","wikidata":"https://www.wikidata.org/wiki/Q17162664","display_name":"Epigenetic regulation of neurogenesis","level":5,"score":0.45730000734329224},{"id":"https://openalex.org/C91965660","wikidata":"https://www.wikidata.org/wiki/Q415875","display_name":"Methyltransferase","level":4,"score":0.4350000023841858},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.421099990606308},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41620001196861267},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39800000190734863},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3725999891757965},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33640000224113464},{"id":"https://openalex.org/C121912465","wikidata":"https://www.wikidata.org/wiki/Q3589153","display_name":"Epigenomics","level":5,"score":0.3346000015735626},{"id":"https://openalex.org/C2910921701","wikidata":"https://www.wikidata.org/wiki/Q1036906","display_name":"Histone Acetyltransferases","level":4,"score":0.32690000534057617},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3253999948501587},{"id":"https://openalex.org/C150425827","wikidata":"https://www.wikidata.org/wiki/Q2560317","display_name":"Histone methyltransferase","level":4,"score":0.3215999901294708},{"id":"https://openalex.org/C2780737395","wikidata":"https://www.wikidata.org/wiki/Q18353741","display_name":"Epigenetic therapy","level":5,"score":0.30309998989105225},{"id":"https://openalex.org/C2778001298","wikidata":"https://www.wikidata.org/wiki/Q1036906","display_name":"Histone acetyltransferase","level":4,"score":0.2955999970436096},{"id":"https://openalex.org/C2776202225","wikidata":"https://www.wikidata.org/wiki/Q3569101","display_name":"Histone deacetylase inhibitor","level":5,"score":0.2615000009536743},{"id":"https://openalex.org/C33288867","wikidata":"https://www.wikidata.org/wiki/Q518328","display_name":"Methylation","level":3,"score":0.2574999928474426},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.25540000200271606}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3390/pharmaceutics18010115","doi":"https://doi.org/10.3390/pharmaceutics18010115","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics18010115","pdf_url":"https://www.mdpi.com/1999-4923/18/1/115/pdf?version=1768575221","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:41599222","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41599222","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:c5f2cc78b9d5481fa27cdb5f040299fb","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c5f2cc78b9d5481fa27cdb5f040299fb","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics, Vol 18, Iss 1, p 115 (2026)","raw_type":"article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12844687","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12844687/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmaceutics","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.3390/pharmaceutics18010115","doi":"https://doi.org/10.3390/pharmaceutics18010115","is_oa":true,"landing_page_url":"https://doi.org/10.3390/pharmaceutics18010115","pdf_url":"https://www.mdpi.com/1999-4923/18/1/115/pdf?version=1768575221","source":{"id":"https://openalex.org/S30283931","display_name":"Pharmaceutics","issn_l":"1999-4923","issn":["1999-4923"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutics","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6208969950675964,"id":"https://metadata.un.org/sdg/1","display_name":"No poverty"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7124288317.pdf","grobid_xml":"https://content.openalex.org/works/W7124288317.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Epigenetics":[0],"involves":[1],"heritable":[2],"changes":[3],"in":[4,53],"gene":[5],"expression-such":[6],"as":[7,95,108,121],"DNA":[8,27,68],"methylation":[9],"(5-methylcytosine;":[10],"5mC),":[11],"histone":[12,60,64],"modifications,":[13],"and":[14,72,78,101,143],"regulation":[15],"by":[16],"non-coding":[17],"RNAs":[18],"at":[19,35],"the":[20,25,36,43,141],"mRNA":[21],"translation":[22],"level-without":[23],"altering":[24],"underlying":[26],"sequence.":[28],"As":[29],"targeting":[30],"these":[31,88,132],"mechanisms":[32],"enables":[33],"intervention":[34],"root":[37],"cause":[38],"of":[39,145,149],"disease":[40],"rather":[41],"than":[42],"symptoms":[44],"alone,":[45],"epigenetics":[46],"has":[47],"become":[48],"a":[49],"rapidly":[50],"advancing":[51],"field":[52],"pharmaceutical":[54],"sciences.":[55],"Various":[56],"epigenetic":[57,127,150],"modulators,":[58],"including":[59],"deacetylase":[61],"(HDAC)":[62],"inhibitors,":[63,67,71],"acetyltransferase":[65],"(HAT)":[66],"methyltransferase":[69],"(DNMT)":[70],"microRNAs":[73],"(miRNAs),":[74],"have":[75,80],"been":[76,82],"developed,":[77],"some":[79],"already":[81],"approved":[83],"for":[84],"cancer":[85],"therapy.":[86],"However,":[87],"agents":[89],"often":[90],"face":[91],"significant":[92],"challenges":[93],"such":[94,153],"poor":[96],"membrane":[97],"permeability,":[98],"enzymatic":[99],"instability,":[100],"suboptimal":[102],"biodistribution.":[103],"Incorporating":[104],"functionalized":[105,154],"accessory":[106,155],"units-serving":[107],"vectors":[109],"(e.g.,":[110,123],"transporter":[111],"recognition":[112],"units,":[113],"cell-penetrating":[114],"peptides,":[115,117],"tumor-homing":[116],"monoclonal":[118,124],"antibodies)":[119],"or":[120],"carriers":[122],"antibodies,":[125],"nanoparticles)-into":[126],"modulators":[128],"may":[129],"help":[130],"overcome":[131],"delivery":[133,148],"barriers.":[134],"In":[135],"this":[136],"narrative":[137],"review,":[138],"I":[139],"discuss":[140],"potential":[142],"advantages":[144],"effective":[146],"non-invasive":[147],"drugs":[151],"using":[152],"unit":[156],"conjugates.":[157]},"counts_by_year":[],"updated_date":"2026-09-23T05:00:35.095934","created_date":"2026-01-16T00:00:00"}